Cargando…

Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation

Libman-Sacks endocarditis (LSE), a cardiac complication of systemic lupus erythematosus, is commonly treated with anticoagulation for stroke prevention. We describe a patient with multifocal strokes secondary to LSE, treated with aspirin, without further recurrence. Our case highlights the importanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Michal, Budhram, Adrian, Sposato, Luciano A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288987/
https://www.ncbi.nlm.nih.gov/pubmed/34316811
http://dx.doi.org/10.1016/j.jaccas.2019.06.032
_version_ 1783724203112923136
author Krawczyk, Michal
Budhram, Adrian
Sposato, Luciano A.
author_facet Krawczyk, Michal
Budhram, Adrian
Sposato, Luciano A.
author_sort Krawczyk, Michal
collection PubMed
description Libman-Sacks endocarditis (LSE), a cardiac complication of systemic lupus erythematosus, is commonly treated with anticoagulation for stroke prevention. We describe a patient with multifocal strokes secondary to LSE, treated with aspirin, without further recurrence. Our case highlights the importance of nuanced decision-making regarding antithrombotic choices for stroke prevention in LSE. (Level of Difficulty: Intermediate.)
format Online
Article
Text
id pubmed-8288987
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82889872021-07-26 Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation Krawczyk, Michal Budhram, Adrian Sposato, Luciano A. JACC Case Rep Case Report Libman-Sacks endocarditis (LSE), a cardiac complication of systemic lupus erythematosus, is commonly treated with anticoagulation for stroke prevention. We describe a patient with multifocal strokes secondary to LSE, treated with aspirin, without further recurrence. Our case highlights the importance of nuanced decision-making regarding antithrombotic choices for stroke prevention in LSE. (Level of Difficulty: Intermediate.) Elsevier 2019-09-11 /pmc/articles/PMC8288987/ /pubmed/34316811 http://dx.doi.org/10.1016/j.jaccas.2019.06.032 Text en © 2019 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Krawczyk, Michal
Budhram, Adrian
Sposato, Luciano A.
Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation
title Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation
title_full Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation
title_fullStr Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation
title_full_unstemmed Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation
title_short Ischemic Stroke From Libman-Sacks Endocarditis Not Associated With Antiphospholipid Antibodies: Good Clinical Outcome Without Anticoagulation
title_sort ischemic stroke from libman-sacks endocarditis not associated with antiphospholipid antibodies: good clinical outcome without anticoagulation
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288987/
https://www.ncbi.nlm.nih.gov/pubmed/34316811
http://dx.doi.org/10.1016/j.jaccas.2019.06.032
work_keys_str_mv AT krawczykmichal ischemicstrokefromlibmansacksendocarditisnotassociatedwithantiphospholipidantibodiesgoodclinicaloutcomewithoutanticoagulation
AT budhramadrian ischemicstrokefromlibmansacksendocarditisnotassociatedwithantiphospholipidantibodiesgoodclinicaloutcomewithoutanticoagulation
AT sposatolucianoa ischemicstrokefromlibmansacksendocarditisnotassociatedwithantiphospholipidantibodiesgoodclinicaloutcomewithoutanticoagulation